Centre intégré de cancérologie de Laval, Montreal, Canada, has selected RayStation through the public tender process as its sole treatment planning system, replacing existing systems. The center welcomes residents of Laval and the surrounding areas since 2011.
Centre intégré de cancérologie de Laval is equipped with four linacs, all Elekta Synergy with Agility MLC, as well as advanced imaging systems such as CT, PET-CT and MRI. The center plans for expansion with an additional linac to treat specialized cases.
Key factors for selecting RayStation was its standardization and automation capabilities of the planning process for 3D-CRT and VMAT, additional optimization tools such as multi-criteria optimization (MCO), as well as the speed of dose computation and support for adaptive re-planning.
Fadi Hobeila, Chief Medical Physicist at Centre intégré de cancérologie de Laval says: “We are a highly efficient and integrated cancer center with innovative workflows. We required a fully featured, flexible and efficient treatment planning system that would fit into our workflows and enable a next level of efficiency and quality for our patients. We look forward to implementing RayStation in our department clinically.”
Johan Löf, CEO of RaySearch, says: “We are very glad to see that Centre intégré de cancérologie de Laval chose RayStation as its treatment planning system. The tender process in Canada has been intense and comprehensive. We have done well, and we are now working to effectively support these new centers in Quebec. We are excited to see what the future will bring in our collaboration with Centre intégré de cancérologie de Laval.”
This tender is the fifth public tender won by RaySearch in Canada over the past two years. At least one more RFP (request for proposal) tender in Canada is expected to be released during 2018.
About Centre intégré de cancérologie de Laval
Centre intégré de cancérologie de Laval, a part of Centre intégré de santé et de services sociaux de Laval, was established in 2011, treating 2050 cancer cases annually. CISSS de Laval is dedicated to learning, innovating and excelling in order to provide the Laval population with integrated, accessible and quality health care and social services. Its human capital has more than 10,000 employees and physicians working in 32 facilities. CISSS de Laval is a research and teaching organization affiliated with the Université de Montréal and McGill University.
RayCare* represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.
More information about RaySearch is available at www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59